Chittaranjan Andrade, MD
Clinical and Practical Psychopharmacology
Cannabis Use in Pregnancy and ASD or ADHD in Offspring
December 23, 2024
Although the number of cannabis-exposed pregnancies (with ASD and ADHD as the outcomes) in world literature is small, cannabis use during pregnancy is a clear marker for adverse neurodevelopmental...
Clinical and Practical Psychopharmacology
Understanding Meta-Analysis Using Gestational Exposure to Cannabis and Birth Defects
November 20, 2024
Dr Andrade discusses strengths and limitations of two recent meta-analyses on birth defects associated with cannabis exposure, with a view to providing readers with a deeper understanding of how...
Clinical and Practical Psychopharmacology
Cannabis Use in Pregnancy and Adverse Outcomes
October 30, 2024
This article focuses on the use of cannabis by women during the reproductive lifespan and specifically during pregnancy, and maternal and neonatal outcomes associated with exposure. Two recent large...
Clinical and Practical Psychopharmacology
Epilepsy, Antiepileptic Drugs, and Adverse Pregnancy Outcomes, 2: Major Congenital Malformations
July 3, 2024
This article reviews evidence from a large registry, a population-based study, and a meta-analysis on the risks of major congenital malformation with untreated epilepsy and with exposure to antiepileptic...
Clinical and Practical Psychopharmacology
Epilepsy, Antiepileptic Drugs, and Adverse Pregnancy Outcomes, 1: Recent Research
June 5, 2024
This article provides women who have epilepsy and who use antiepileptic drugs during pregnancy with information about the many risks to which they and their fetus/neonate are exposed at...
Clinical and Practical Psychopharmacology
Diabetic medications and major congenital malformations
March 11, 2024
Diabetes is prevalent and poses risks to both mother and child during pregnancy. Evidence shows that diabetes is best treated during pregnancy, with insulin a first-line treatment and metformin...
